How do SCFAs trigger GLP-1 release
This article examines the current evidence regarding Ozempic and oestrogen levels, explores the indirect effects mediated through weight loss, and provides guidance for women considering or currently taking this medication
While its weight loss and blood sugar control benefits can help with this, studies show that tirzepatide may produce additional cardiovascular benefits
That can create a softer or more deflated appearance
Specifically, patients taking 2.4mg of Wegovy lost up to 17% of their weight over 68 weeks of treatment, while patients taking CagriSema lost up to 22.7% of their body weight in a Phase 3 clinical trial
However, if you continue to experience difficulties, its probably a good time to get a check-up